Drug Shortage Report for LITHANE

Last updated on 2022-03-08 History
Report ID 149006
Drug Identification Number 02013231
Brand name LITHANE
Common or Proper name LITHANE
Company Name ERFA CANADA 2012 INC
Market Status MARKETED
Active Ingredient(s) LITHIUM CARBONATE
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100 CAPS
ATC code N05AN
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-10-15
Actual start date 2021-10-15
Estimated end date 2021-12-28
Actual end date 2022-03-01
Shortage status Resolved
Updated date 2022-03-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1600 NOTRE DAME ST. WEST
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-03-08 French Compare
v3 2022-03-08 English Compare
v2 2021-11-09 French Compare
v1 2021-11-09 English Compare

Showing 1 to 4 of 4